Michael Masnick at Techdirt offers up another incidence of government inconsistency in light of the FTC’s blog-watching rules, reminding us that “clinical research on drugs isn’t even remotely trustworthy, as it all-too-often seems to involve doctors who have serious conflicts.”

Doctors with conflicts-of-interest, who push and promote certain drugs while receiving all kinds of goodies from pharmaceutical companies, seems, at the very least, like a more justifiable place for regulators to stick their noses (although there’s definitely an argument to be made…

Read the full story

Diana Levine suffered from chronic migraine headaches for many years. So, in April 2000, when she went to a local clinic to get treatment, she knew what to expect. She’d received the same treatment several times before: an injection of Demerol for the pain, and an injection of an antihistamine called Phenergan to treat the nausea that accompanies both migraine headaches and Demerol itself. Everything was normal — except for how the drugs were actually administered. The physician’s assistant who gave…

Read the full story